WuXi AppTec Co., Ltd. (OTCMKTS:WUXIF – Get Free Report) shares rose 1.7% on Tuesday. The company traded as high as $26.5175 and last traded at $26.5175. 125 shares were traded during mid-day trading, a decline of 95% from the average session volume of 2,363 shares. The stock had previously closed at $26.08.
WuXi AppTec Stock Performance
The company has a 50 day moving average of $24.28 and a two-hundred day moving average of $19.10.
WuXi AppTec Company Profile
WuXi AppTec is a global contract research, development and manufacturing organization serving the pharmaceutical, biotechnology and medical device industries. The company provides end-to-end solutions spanning discovery biology, medicinal chemistry, preclinical safety assessment, clinical trial support, and large-scale manufacturing of small molecules, biologics and advanced therapies. By integrating scientific expertise with state-of-the-art laboratory and production facilities, WuXi AppTec enables clients to accelerate the development of new treatments while managing time and cost pressures.
Key service offerings include custom synthesis and process research for active pharmaceutical ingredients (APIs), biologics development and manufacturing, cell line development, gene therapy support, as well as comprehensive analytical and testing services.
Featured Articles
- Five stocks we like better than WuXi AppTec
- Hims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks
- Paychex Plunges, Providing the Entry Investors Have Been Waiting For
- The Case for Buying High-Yield General Mills Just Strengthened
- SanDisk’s $1,800 Breakout Turns Memory Hardware Into a Profit Story
Receive News & Ratings for WuXi AppTec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for WuXi AppTec and related companies with MarketBeat.com's FREE daily email newsletter.
